A Therapeutic and Diagnostic Multidisciplinary Pathway for Merkel Cell Carcinoma Patients

Merkel Cell Carcinoma (MCC) is a highly aggressive neuroendocrine neoplasm of the skin. Due to its rarity, the management of MCC is not standardized across centers. In this article, we present the experience of the Veneto region in the North-East of Italy, where a committee of skin cancer experts ha...

Descripción completa

Detalles Bibliográficos
Autores principales: Rastrelli, Marco, Del Fiore, Paolo, Buja, Alessandra, Vecchiato, Antonella, Rossi, Carlo Riccardo, Chiarion Sileni, Vanna, Tropea, Saveria, Russano, Francesco, Zorzi, Manuel, Spina, Romina, Cappellesso, Rocco, Mazzarotto, Renzo, Cavallin, Francesco, Bassetto, Franco, Bezzon, Elisabetta, Ferrazzi, Beatrice, Alaibac, Mauro, Mocellin, Simone
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7174780/
https://www.ncbi.nlm.nih.gov/pubmed/32351898
http://dx.doi.org/10.3389/fonc.2020.00529
Descripción
Sumario:Merkel Cell Carcinoma (MCC) is a highly aggressive neuroendocrine neoplasm of the skin. Due to its rarity, the management of MCC is not standardized across centers. In this article, we present the experience of the Veneto region in the North-East of Italy, where a committee of skin cancer experts has proposed a clinical pathway for the diagnosis and treatment of MCC. Putting together the evidence available in the international literature, we outlined the best approach to the management of patients affected with this malignancy step- by- step for each possible clinical situation. Crucial in this pathway is the role of the multidisciplinary team to deal with the lack of robust information on each aspect of the management of this disease.

Ejemplares similares